What is Flashback Technologies?
Flashback Technologies specializes in leveraging advanced machine learning to convert disparate medical data into actionable insights. Their core offering, the FDA-cleared CipherOx CRI-M1, functions as a blood loss monitor, tracking acute blood loss via the Compensatory Reserve Index. The company's solutions are designed for healthcare organizations, researchers, and life-science teams, aiming to enhance clinical monitoring, streamline operational efficiency, and support regulatory compliance. By providing enhanced analytical clarity, Flashback Technologies empowers innovation within clinical and research settings.
How much funding has Flashback Technologies raised?
Flashback Technologies has raised a total of $3.5M across 2 funding rounds:
Series A
$2.3M
Private Equity
$1.2M
Series A (2014): $2.3M with participation from Pacific Advantage Capital
Private Equity (2016): $1.2M, investors not publicly disclosed
Key Investors in Flashback Technologies
Pacific Advantage Capital
Pacific Advantage Capital is a global investment partnership focused on special situations, private equity, and growth equity, seeking compelling risk-adjusted returns across various markets and capital structures.
What's next for Flashback Technologies?
The recent major strategic investment suggests Flashback Technologies is poised for significant scaling and market penetration. This enterprise-level funding will likely fuel further development of their AI-driven medical data solutions and expand their reach within the healthcare and life sciences sectors. The company's focus on improving decision-making through data intelligence positions it for continued growth and impact in critical healthcare applications.
See full Flashback Technologies company page
